Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, semaglutide can make you feel tired, and fatigue is listed as a recognised side effect in clinical trial data and on the NHS medicines information for semaglutide. It tends to be most noticeable in the first few weeks of treatment or after a dose increase, and for most people it eases as the body adjusts. That said, tiredness during Wegovy treatment is not universal, and the reasons behind it are worth understanding — because not all fatigue on semaglutide has the same cause. These are prescription-only medicines, and a GPhC-registered prescriber assesses every individual's suitability and monitors how treatment is going.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial (the pivotal phase 3 study of semaglutide 2.4mg published in the New England Journal of Medicine) enrolled 1,961 adults with obesity and tracked adverse events carefully over 68 weeks. Fatigue appeared as a reported side effect, predominantly in the early months, and was classified as generally mild to moderate in severity. It was not among the most common complaints (that distinction belongs to nausea, vomiting and diarrhoea), but it was consistent enough to feature in the safety profile.
The NHS patient information for semaglutide lists tiredness explicitly among the side effects that some people experience, particularly during the titration phase. This matters because it confirms that feeling worn out in the first few weeks is not a sign that something has gone wrong, it is a known pattern that prescribers anticipate.
A question our prescribers hear most weeks is whether the tiredness means the medicine isn't agreeing with someone. Usually it does not. The more useful question is whether the fatigue is improving, staying flat or getting worse, and that distinction is what guides clinical decisions about whether to hold a dose or continue titrating.
The direct mechanism is one part of the picture. Semaglutide slows gastric emptying and acts on appetite-regulating pathways in the brain, which reduces hunger markedly, and when appetite falls sharply, many people eat significantly less than their body is used to. A meaningful calorie deficit, especially a sudden one, can cause fatigue on its own, independent of any drug effect.
Nausea compounds this further. When you feel sick, eating becomes difficult, and if you're not managing adequate protein or fluid, energy levels drop. Some people who find they are particularly tired on Wegovy are actually mildly dehydrated, because the same nausea that suppresses appetite also discourages drinking enough, and if you want to understand how semaglutide can make you feel sick and why that happens, our page covers the causes and what tends to help. If you want to understand whether semaglutides make you tired and why that happens, our page covers the mechanisms in detail alongside nausea and other contributing factors.
The dose-adjustment schedule also plays a role. Tiredness is more frequently reported at the lower starting doses when the body is calibrating to the medicine, not at the maintenance dose. This counterintuitive pattern reflects the fact that the gut and central nervous system are still adapting; it is not a dose-dependent effect in the traditional sense.
Most fatigue during Wegovy treatment is self-limiting and manageable. The threshold for contacting a prescriber shifts when tiredness is severe, does not improve after two to three weeks, or arrives alongside symptoms that suggest something else is happening. Dehydration from prolonged vomiting or diarrhoea can tip into a more serious problem; the NHS guidance on semaglutide advises getting medical help if you become severely dehydrated, which can affect the kidneys.
Exhaustion paired with severe, persistent stomach pain (particularly pain that radiates towards the back) is a different matter entirely. That combination should prompt same-day medical assessment, because acute pancreatitis is a rare but serious risk with GLP-1 medicines. Our page on Wegovy and pancreatitis symptoms explains what to watch for. Separately, very low mood or persistent changes in mental state during treatment are also worth raising with a clinician promptly.
For a broader picture of what to expect across the full side-effect profile, the Wegovy side effects page brings together the complete documented range.
Because reduced appetite is central to how semaglutide works, eating less is partly the point, but eating too little too quickly makes fatigue worse. Prioritising protein at each meal (eggs, fish, chicken, Greek yoghurt, pulses) helps maintain muscle and steadier energy, even when portions are small. Hydration matters just as much: sipping water regularly through the day, even without feeling thirsty, offsets the fluid deficits that nausea can create.
Gentle, consistent movement (a short walk, some light resistance work) tends to support energy better than complete rest, although intense exercise on a significantly reduced intake can backfire. If you are wondering specifically whether taking semaglutide makes you tired and how long that typically lasts, our dedicated page looks at the pattern in more detail, including what tends to help. Sleep quality and stress both amplify fatigue too, and are worth factoring in when assessing how you're coping on treatment.
If you're thinking about whether Wegovy is the right option for you, the Wegovy treatment overview sets out how the medicine works, who it is licensed for and what the process involves. For anyone already on treatment who has concerns about persistent side effects, the right first step is a conversation with your prescriber, our free consultation gives you access to a GPhC-registered prescriber who reviews your case personally, the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.